Physician profile
Peter Dean Cummings
NPI 1942285978
$139,632.23
in general payments reported to CMS, 2019-2025
23 companies · $46K in 2025
The $46K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $13K · 2021: $14K · 2022: $11K · 2023: $9,719 · 2024: $8,120 · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Royalty Or License: $24K · Travel and Lodging: $9,027 · Food and Beverage: $1,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,759.00 |
| Royalty Or License | $24,185.18 |
| Travel and Lodging | $9,027.09 |
| Food and Beverage | $1,779.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $97,616.66 | 2019-2025 | Biowick X |
| Amgen INC. | $40,040.22 | 2019-2025 | Evenity, Prolia |
| Radius Health, INC. | $355.51 | 2019-2023 | Tymlos |
| Horizon Therapeutics Plc | $272.90 | 2019-2020 | |
| Anika Therapeutics, INC. | $170.50 | 2021 | |
| Ferring Pharmaceuticals INC. | $152.89 | 2019-2022 | |
| Abbott Laboratories | $138.48 | 2025 | Proclaim |
| Smith+Nephew, INC. | $124.05 | 2019-2022 | |
| Arthrex, INC. | $120.92 | 2020 | |
| Arthrosurface Incorporated | $108.43 | 2020 | |
| Ucb, INC. | $99.14 | 2022-2023 | |
| Ethicon US, LLC | $66.58 | 2019-2021 | |
| Bioventus LLC | $65.88 | 2019-2022 | |
| Stryker Corporation | $50.00 | 2019 | |
| Pacira Therapeutics, INC. | $46.81 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $42.01 | 2019-2023 | Hymovis |
| Impactortho, INC. | $39.14 | 2025 | |
| Dynasplint Systems INC. | $22.31 | 2022 | |
| Depuy Synthes Sales INC. | $21.58 | 2019 | |
| Orthogenrx INC. | $20.76 | 2019 | |
| Electronic Waveform Lab, INC. | $20.67 | 2019-2020 | |
| Orthofix Medical, INC. | $18.46 | 2019-2020 | |
| Vericel Corporation | $18.33 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.